Eiko Lifesciences consolidated net profit rises 23.81% in the March 2026 quarter

Sales rise 62.73% to Rs 18.34 crore

Net profit of Eiko Lifesciences rose 23.81% to Rs 1.30 crore in the quarter ended March 2026 as against Rs 1.05 crore during the previous quarter ended March 2025. Sales rose 62.73% to Rs 18.34 crore in the quarter ended March 2026 as against Rs 11.27 crore during the previous quarter ended March 2025.

For the full year,net profit rose 113.27% to Rs 4.50 crore in the year ended March 2026 as against Rs 2.11 crore during the previous year ended March 2025. Sales rose 39.96% to Rs 52.71 crore in the year ended March 2026 as against Rs 37.66 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	18.34	11.27	63	52.71	37.66	40
OPM %	12.32	11.62	-	14.10	7.33	-
PBDT	2.27	1.55	46	8.13	3.46	135
PBT	2.02	1.30	55	7.12	2.72	162
NP	1.30	1.05	24	4.50	2.11	113

Powered by Capital Market - Live News